Prospective, non-randomised, interventional cohort case series. A total of 27 eyes of 27 patients with diabetic macular oedema received an intravitreal injection of 4 mg (0.1 ml) of triamcinolone ...
To evaluate the clinical and visual outcome of an intravitreal injection of triamcinolone in patients with diabetic macular oedema refractory to laser treatment. The average duration of macular oedema ...
May 7, 2003 — Intravitreal injection of triamcinolone is helpful in patients with refractory diabetic macular edema, according to a presentation on May 7 at the Association for Research in Vision and ...
December 22, 2009 — Intravitreal use of the corticosteroid triamcinolone may slow the progression of diabetic retinopathy, but adverse effects including cataract formation and glaucoma may prevent use ...
FDA receives reports of serious adverse events after triamcinolone, moxifloxacin compound injections
Please provide your email address to receive an email when new articles are posted on . The FDA is warning clinicians about serious adverse events reported after intravitreal injections of ...
Please provide your email address to receive an email when new articles are posted on . The retrospective longitudinal comparative study included 681 eyes (group 1) that received Tri-Moxi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback